AlphaCentric Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

AlphaCentric Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-250,000	Closed	-$57.5K	–	259
2024 Q1	$57.5K	Sell	250,000 -50,000	-17%	-$14.5K	0.03%	214
2023 Q4	$95.7K	Sell	300,000 -200,000	-40%	-$51.6K	0.06%	171
2023 Q3	$135K	Hold	500,000	–	–	0.08%	171
2023 Q2	$253K	Hold	500,000	–	–	0.14%	122
2023 Q1	$329K	Buy	+500,000	New	+$339K	0.23%	102
2021 Q2	–	Sell	-150,000	Closed	-$488K	–	245
2021 Q1	$488K	Buy	+150,000	New	+$543K	0.16%	48

Other funds holding ASXC

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AlphaCentric Advisors's ASXC Position: Q2 2024 in Review

AlphaCentric Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 250,000 shares — an estimated $57.5K sold.

AlphaCentric Advisors first reported a position in ASXC in Q1 2021 and held it in 6 quarters. The position peaked at $488K in Q1 2021. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

AlphaCentric Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
AlphaCentric Advisors sold 250,000 Asensus Surgical, Inc. shares in Q2 2024, an estimated $57.5K.
AlphaCentric Advisors first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 6 quarters.
AlphaCentric Advisors's Asensus Surgical, Inc. position peaked at $488K in Q1 2021.
64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on AlphaCentric Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.